title: Failure rate: Why many cancer drugs don't receive FDA approval, and what can be done about it.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001549:Benzamides / Q000494:pharmacology; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004345:Drug Industry; D006801:Humans; D058990:Molecular Targeted Therapy / Q000592:standards / Q000639:trends; D054547:National Cancer Institute (U.S.); D061366:Numbers Needed To Treat / Q000592:standards / Q000639:trends; D018579:Patient Selection; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D057285:Precision Medicine / Q000639:trends; D012109:Research Support as Topic; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; C090712:iniparib